Page last updated: 2024-08-20

nafcillin and cefotaxime

nafcillin has been researched along with cefotaxime in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	8 (44.44)	18.7374
1990's	2 (11.11)	18.2507
2000's	3 (16.67)	29.6817
2010's	5 (27.78)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albron, W; Bell, FW; Draheim, SE; Jordan, CL; Kasher, JS; Pike, AJ; Preston, DA; Ternansky, RJ; West, SJ; Wu, CY	1
Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Anderson, KC; Kellogg, GE; Sarkar, A	1
Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Holloway, JJ; Lietman, PS; Moore, RD; Smith, CR	1
Lietman, PS; Moore, RD; Smith, CR	2
Paul, TO; Wilson, ME	1
Berk, SL	1
Ambinder, R; Israel, E; Levitt, R; Lietman, PS; Lipsky, JJ; Longstreth, J; Mellits, ED; Petty, BG; Rocco, L; Smith, CR	1
Chuah, SK; Dhawan, VK; Maier, MK; Nayyar, M; Thadepalli, H	1
Bansal, MB; Chuah, SK; Dhawan, VK; Maier, MK; Nayyar, M; Thadepalli, H	1
Chanda, PK; Mehta, S; Paul, A; Plata, KB; Riosa, S; Rosato, AE; Rosato, RR; Singh, C	1
Berti, AD; Nizet, V; Nonejuie, P; Olson, J; Pogliano, J; Proctor, RA; Rose, WE; Sakoulas, G; Sauer, JD; Theisen, E	1

Reviews

1 review(s) available for nafcillin and cefotaxime

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

4 trial(s) available for nafcillin and cefotaxime

Article	Year
Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness. Archives of internal medicine, 1986, Volume: 146, Issue:6 Topics: Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Cost-Benefit Analysis; Double-Blind Method; Fees and Charges; Humans; Kidney; Maryland; Nafcillin; Random Allocation; Regression Analysis; Time Factors; Tobramycin	1986
Studies of risk factors for aminoglycoside nephrotoxicity. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1986, Volume: 8, Issue:5 Topics: Acute Kidney Injury; Age Factors; Aminoglycosides; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Humans; Kidney Diseases; Nafcillin; Probability; Risk; Time Factors; Tobramycin	1986
Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides. The American journal of medicine, 1986, Volume: 80, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Double-Blind Method; Female; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Nafcillin; Tobramycin	1986
Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial. Annals of internal medicine, 1984, Volume: 101, Issue:4 Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infusions, Parenteral; Kidney Diseases; Male; Middle Aged; Nafcillin; Penicillin Resistance; Prognosis; Pseudomonas Infections; Random Allocation; Tobramycin; Urinary Tract Infections	1984

Other Studies

13 other study(ies) available for nafcillin and cefotaxime

Article	Year
Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus. Journal of medicinal chemistry, 1993, Jul-09, Volume: 36, Issue:14 Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Cephalosporins; Half-Life; Humans; Macaca mulatta; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Staphylococcus aureus; Structure-Activity Relationship	1993
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:2 Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis	1999
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics. European journal of medicinal chemistry, 2012, Volume: 52 Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics	2012
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:4 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship	2013
Orbital cellulitis following strabismus surgery. Ophthalmic surgery, 1987, Volume: 18, Issue:2 Topics: Cefotaxime; Cellulitis; Child, Preschool; Drug Therapy, Combination; Female; Humans; Nafcillin; Orbital Diseases; Postoperative Complications; Strabismus; Tomography, X-Ray Computed	1987
Cefotaxime and nafcillin-tobramycin. Annals of internal medicine, 1985, Volume: 102, Issue:2 Topics: Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Humans; Nafcillin; Tobramycin	1985
In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus. Chemotherapy, 1984, Volume: 30, Issue:5 Topics: Anti-Bacterial Agents; Cefazolin; Cefmenoxime; Cefotaxime; Endocarditis, Bacterial; Humans; Microbial Sensitivity Tests; Moxalactam; Nafcillin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	1984
Newer beta-lactam antibiotics in the treatment of experimental Staphylococcus aureus endocarditis. The Journal of antimicrobial chemotherapy, 1984, Volume: 14, Issue:2 Topics: Animals; Cefmenoxime; Cefotaxime; Endocarditis, Bacterial; Humans; Male; Microbial Sensitivity Tests; Moxalactam; Nafcillin; Rabbits; Staphylococcal Infections	1984
β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12 Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Daptomycin; DNA; Drug Resistance, Bacterial; Drug Synergism; Imipenem; Insecta; Larva; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Nafcillin; Oxacillin; Staphylococcal Infections	2012
Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam-Daptomycin Synergy. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Anti-Bacterial Agents; Cefaclor; Cefotaxime; Cefoxitin; Ceftriaxone; Cell Membrane; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation, Bacterial; Imipenem; Meropenem; Methicillin-Resistant Staphylococcus aureus; Models, Statistical; Nafcillin; Penicillin-Binding Proteins; Promoter Regions, Genetic; Protein Isoforms; Thienamycins; Transcription, Genetic	2016